[1]徐道情,黄维琛,欧梁,等.基于中医传承辅助平台挖掘《正体类要》中治伤内服方剂的用药规律[J].中医正骨,2021,33(12):14-18.
　XU Daoqing,HUANG Weichen,OU Liang,et al.A data mining-based analysis of clinical medication rules of oral prescriptions for treatment of orthopedic and traumatic diseases in Classification and Treatment of Traumatic Diseases using traditional Chinese medicine inheritance support system[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2021,33(12):14-18.
点击复制

基于中医传承辅助平台挖掘《正体类要》中治伤内服方剂的用药规律()
分享到：

《中医正骨》[ISSN:1001-6015/CN:41-1162/R]

卷:
第33卷
期数:
2021年12期
页码:
14-18
栏目:
文献研究
出版日期:
2021-12-20

文章信息/Info

Title:
A data mining-based analysis of clinical medication rules of oral prescriptions for treatment of orthopedic and traumatic diseases in Classification and Treatment of Traumatic Diseases using traditional Chinese medicine inheritance support system
作者:
徐道情1; 黄维琛2; 欧梁2; 孔德忠1; 杨先宇1; 付兴前1
(1.贵州中医药大学骨伤学院,贵州 贵阳 550002; 2.贵州中医药大学第二附属医院,贵州 贵阳 550003)
Author(s):
XU Daoqing1; HUANG Weichen2; OU Liang2; KONG Dezhong1; YANG Xianyu1; FU Xingqian1
1.The College of Traumatology and Orthopedics of Guizhou University of Traditional Chinese Medicine,Guiyang 550002,Guizhou,China2.The Second Affiliated Hospital of Guizhou University of Traditional Chinese Medicine,Guiyang 550003,Guizhou,China
关键词:
中医药学文献;  数据挖掘;  方剂构成;  组方原则;  聚类分析;  正体类要
Keywords:
medicine pharmacologic literature(TCM);  data mining;  constitution of formula;  formula composing principles;  cluster analysis;  Classification and Treatment of Traumatic Diseases
摘要:
目的:挖掘《正体类要》中治伤内服方剂的用药规律。方法:收集《正体类要》中的治伤内服方剂,利用中医传承辅助平台(V2.5)对数据进行统计分析,挖掘方剂的用药规律。结果:共收集到57首方剂,涉及116味中药,其中出现频次≥5的中药有19味,排在前3位的分别是当归、甘草、人参。57首内服治伤方剂的组方药物中,药性以温性出现频次最多、其次为寒性,药味以甘味出现频次最多、其次为苦和辛味,归经以脾经出现频次最多、其次为肝经; 出现频次≥10的药物组合有8个,排在前3位的为人参-甘草、人参-茯苓、甘草-茯苓; 核心药物组合10个,分别为羌活-防风-细辛、桃仁-红花-瓜蒌、茯苓-甘草-大枣等。经聚类分析得到新处方5首。结论:《正体类要》中治伤内服方剂多采用性温、味甘、归脾经的药物; 核心药物组合以活血化瘀、解表止痛、益气补血药物为主; 以核心药物组合为基础聚类出的内服治伤新方,可为临床用药提供参考,但其疗效有待进一步研究。
Abstract:
Objective:To excavate the clinical medication rules of oral prescriptions for treatment of orthopedic and traumatic diseases in Classification and Treatment of Traumatic Diseases.Methods:The oral prescriptions aimed at treating orthopedic and traumatic diseases were extracted from the Classification and Treatment of Traumatic Diseases and were statistically analyzed by using traditional Chinese medicine inheritance support system(TCMISS)software(V2.5)for excavating the clinical medication rules.Results:Fifty-seven oral prescriptions were included in the final analysis,involving 116 Chinese herbs,among which 19 ones displayed a occurrence frequency of≥5,and the top 3 ones with high occurrence frequency included Angelica sinensis,Glycyrrhiza uralensis and Ginseng Radix et Rhizoma.Among the 57 oral prescriptions,the most frequently appeared Chinese herbs were those with a warm property,followed by the ones with a cold property; and the ones with sweet flavors were more preferred,followed by bitter and pungent flavors,and they mainly acted on the spleen meridians and liver meridians.The occurrence frequency were≥10 in 8 herb combinations,and the top 3 ones with high occurrence frequency included Ginseng Radix et Rhizoma-Glycyrrhiza uralensis,Ginseng Radix et Rhizoma-Poria(TCD)and Glycyrrhiza uralensis-Poria(TCD); The cluster analysis on all the included Chinese herbs generated 10 core herb combinations,namely Notopterygii Rhizoma et Radix-Saposhnikoviae Radix-Asari Radix et Rhizoma(TCD),Persicae Semen-Carthamus tinctorius-Trichosanthis Fructus,Poria(TCD)-Glycyrrhiza uralensis-Jujubae Fructus and so on,and 5 new prescriptions were dug out.Conclusion:The Chinese herbs are often the ones presented with warm property and sweet flavor and mainly act on spleen meridians in the oral prescriptions aimed at treating orthopedic and traumatic diseases in Classification and Treatment of Traumatic Diseases,and the core herb combinations are mainly the ones for activating blood and removing stasis,relieving exterior syndrome and alleviating pain as well as tonifying qi and nourishing blood.The new prescriptions clustered based on core herb combinations can provide references for clinical medication,while their curative effects need to be further studied.

参考文献/References:

[1] 牛永涛,谢林,席志鹏,等.《正体类要》气血脏腑辨证论治思想初探[J].中医正骨,2019,31(7):75-76.
[2] 楼毅杰,黄宇丹,陈凌菲.《正体类要》治瘀法探析[J].中医文献杂志,2018,36(4):15-17.
[3] 张锡纯.医学衷中参西录[M].北京:化学工业出版社,2018:224-225.
[4] 黄红泓,覃日宏,柳贤福.中药当归的化学成分分析与药理作用探究[J].世界最新医学信息文摘,2019,19(58):127.
[5] WEI W L,ZENG R,GU C M,et al.Angelica sinensis in China-a review of botanical profile,ethnopharmacology,phytochemistry and chemical analysis[J].J Ethnopharmacol,2016,190:116-141.
[6] 张介宾.景岳全书[M].北京:人民卫生出版社,2007:1198-1201.
[7] HOSSEINZADEH H,NASSIRI-ASL M.Pharmacological effects of glycyrrhiza spp and its bioactive constituents:update and review[J].Phytother Res,2015,29(12):1868-1886.
[8] GUO J,YANG C,YANG J,et al.Glycyrrhizic acid ameliorates cognitive impairment in a rat model of vascular dementia associated with oxidative damage and inhibition of voltage-gated sodium channels[J].CNS Neurol Disord Drug Targets,2016,15(8):1001-1008.
[9] HAN S,SUN L,HE F,et al.Anti-allergic activity of glycyrrhizic acid on IgE-mediated allergic reaction by regulation of allergy-related immune cells[J].Sci Rep,2017,7(1):7222.
[10] 李晓红,齐云,蔡润兰,等.甘草总皂苷抗炎作用机制研究[J].中国实验方剂学杂志,2010,16(5):110-113.
[11] KUDO T,OKAMURA S,ZHANG Y,et al.Topical application of glycyrrhizin preparation ameliorates experimentally induced colitis in rats[J].World J Gastroenterol,2011,17(17):2223-2228.
[12] 陈士铎.本草新编[M].北京:中国中医药出版社,2008:61-64.
[13] 孙睿,张建文,梁辉,等.人参皂苷Rg1对大鼠Ⅲ型前列腺炎血清细胞免疫因子的影响[J].四川中医,2017,35(2):54-56.
[14] 凌露,杨萍,盖盛坤,等.人参皂苷Rg1通过自噬抑制Raw264.7巨噬细胞凋亡[J].解剖学报,2016,47(5):599-606.
[15] 王欢,侯殿东,陈文娜,等.人参多糖对NK92-MI细胞杀伤活性的影响及机制[J].中国民族民间医药,2017,26(9):37-39.
[16] 佟彤,董文茜,梁晓雨,等.人参多糖免疫调节作用的实验研究[J].北京中医药,2016,35(1):41-45.
[17] 贾立云,潘晓华,刘晶,等.人参皂苷Rb1、Re对Aβ_(25-35)诱导SK-N-SH细胞损伤的保护作用[J].山东大学学报(医学版),2011,49(4):33-37.
[18] 罗浩铭,王颖,陈英红,等.人参糖蛋白对Aβ_(25～35)诱导SH-SY5Y细胞凋亡的影响[J].中国老年学杂志,2016,36(24):6077-6080.
[19] 王拥军,梁倩倩,崔学军,等.调和气血法防治慢性筋骨病的应用与发展[J].上海中医药杂志,2017,51(6):1-4.
[20] 李晓锋,王拥军,莫文,等.耕耘杏林济世春秋——施杞教授与石筱山伤科学术经验继承创新[J].上海中医药杂志,2017,51(1):1-4.
[21] 李梴.医学入门[M].北京:人民卫生出版社,2006:766-772.
[22] 胡劲松.理伤宜从气血津精论治[J].中医正骨,2005,17(3):49-50.
[23] 高樱,杨龙飞,翟阳,等.具有活血化瘀功效的中药药理作用及机制研究进展[J].中华中医药杂志,2018,33(11):5053-5056.
[24] 陈晨,刘倩,高华.活血化瘀药药理作用研究进展[J].中国药事,2011,25(6):603-605.
[25] 倪强,陈宏伟,姜宏森.活血化瘀方联合PFNA内固定对股骨粗隆间骨折患者髋关节功能和血流变学的影响[J].长春中医药大学学报,2017,33(6):951-954.
[26] 方振林,戴燚,刘军.活血化瘀汤联合VSD负压引流治疗对SandersⅡ型跟骨骨折患者术后切口愈合及术后并发症的影响[J].四川中医,2020,38(1):146-149.
[27] 吴鹏飞,王培民,范竞.伤科古籍中熏洗方的关联规则分析[J].吉林中医药,2012,32(3):288-290.
[28] 张立军.活血化瘀结合解表发散法治疗急性软组织损伤疗效观察[J].广西中医药,2015,38(3):26-27.

相似文献/References:

[1]李刚,程春生.股骨头坏死血瘀证症状与平乐郭氏正骨方药药物组成 最大频繁关联模式挖掘[J].中医正骨,2015,27(04):21.
　LI Gang,CHENG Chunsheng.Maximal frequent association pattern mining for studying the relationship between BLOOD STASIS syndrome in patients with osteonecrosis of femoral head and drug components of Pingle Guo's orthopedics prescription[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(12):21.
[2]林洁,范展彪,刘献祥.基于数据挖掘技术探讨陈可冀《清宫配方集成》中治疗骨关节炎组方的用药规律[J].中医正骨,2017,29(11):15.
　LIN Jie,FAN Zhanbiao,LIU Xianxiang.Study on medication rule extracted from prescription for treatment of osteoarthritis in Royal Formulary of Qing Dynasty written by Chen Keji based on data mining techniques[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2017,29(12):15.
[3]杨波,袁普卫,康武林,等.基于数据挖掘法探讨李堪印教授治疗强直性脊柱炎的用药规律[J].中医正骨,2020,32(11):74.
[4]李文浩,牛逸群,谭明生.基于数据挖掘法探讨中医药治疗脊髓型颈椎病的用药规律[J].中医正骨,2021,33(01):22.
　LI Wenhao,NIU Yiqun,TAN Mingsheng.A study of medication rule of Traditional Chinese Medicine for treatment of cervical spondylotic myelopathy based on data mining approach[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2021,33(12):22.
[5]顾勇,赵艳明,童培建,等.基于数据挖掘法探讨中药复方治疗股骨头坏死的组方规律[J].中医正骨,2021,33(06):49.
　GU Yong,ZHAO Yanming,TONG Peijian,et al.A study of medication rule of Traditional Chinese Medicine compounds for treatment of osteonecrosis of femoral head based on data mining approach[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2021,33(12):49.
[6]张亚运,许金海,莫文.基于数据挖掘法分析腰椎椎管狭窄症中药外用方的用药规律[J].中医正骨,2021,33(08):28.
　ZHANG Yayun,XU Jinhai,MO Wen.Medication rules of external-applied Chinese herbal medicine prescriptions for treatment of lumbar spinal stenosis:a data mining-based analysis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2021,33(12):28.
[7]赵睿晞,王人彦.张玉柱教授治疗腰椎间盘突出症的用药规律分析[J].中医正骨,2021,33(08):39.
　ZHAO Ruixi,WANG Renyan.An analysis of clinical medication rules of Professor ZHANG Yuzhu in treatment of lumbar disc herniation[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2021,33(12):39.
[8]张杰,丁权威,张玉柱,等.基于数据挖掘法探讨张玉柱教授治疗神经根型颈椎病的辨证用药规律[J].中医正骨,2021,33(11):41.
　ZHANG Jie,DING Quanwei,ZHANG Yuzhu,et al.Clinical medication rules of Professor ZHANG Yuzhu in treatment of nerve-root type cervical spondylosis based on syndrome differentiation principles:a data mining-based study[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2021,33(12):41.
[9]左世国,李姣姣,向昱阳.《医宗金鉴·正骨心法要旨》中骨伤外治处方的用药规律分析[J].中医正骨,2022,34(02):40.
　ZUO Shiguo,LI Jiaojiao,XIANG Yuyang.Clinical medication rules of the prescriptions for external treatment of orthopedic and traumatic diseases in Yizong Jinjian,Essentials of Bone Orthopedics[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2022,34(12):40.
[10]祁建华,明洪,张会择,等.基于数据挖掘法探讨《世医得效方》中治伤方剂的用药规律[J].中医正骨,2022,34(03):20.
　QI Jianhua,MING Hong,ZHANG Huize,et al.A data mining-based analysis of clinical medication rules of prescriptions for treatment of orthopedic and traumatic diseases in Shiyi Dexiao Fang[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2022,34(12):20.
[11]王笑青,张丽丽,沙莎,等.基于中医传承辅助平台挖掘《辨证录》中痹病内服方剂的组方配伍规律[J].中医正骨,2023,35(06):44.
　WANG Xiaoqing,ZHANG Lili,SHA Sha,et al.A data mining-based analysis of clinical medication rules of oral prescriptions for treatment of Bi-diseases in Syndrome Differentiation Record using traditional Chinese medicine inheritance support system[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2023,35(12):44.
[12]黄明翥,周红海,何心愉,等.《医宗金鉴·正骨心法要旨》中治疗伤科瘀肿疼痛方剂的用药规律分析[J].中医正骨,2023,35(10):37.
　HUANG Mingzhu,ZHOU Honghai,HE Xinyu,et al.A data mining-based analysis of clinical medication rules of traumatologic prescriptions for treatment of blood stasis,swelling and pain in Yizong Jinjian,Essentials of Bone Orthopedics[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2023,35(12):37.

备注/Memo

备注/Memo:
通讯作者:黄维琛 E-mail:651562565@qq.com
更新日期/Last Update: 1900-01-01